James George to Middle Aged
This is a "connection" page, showing publications James George has written about Middle Aged.
Connection Strength
1.918
-
Preventable deaths during initial episodes of acquired Thrombotic Thrombocytopenic Purpura: Past and future. Am J Hematol. 2019 09; 94(9):E242-E244.
Score: 0.075
-
Caplacizumab Therapy without Plasma Exchange for Acquired Thrombotic Thrombocytopenic Purpura. N Engl J Med. 2019 07 04; 381(1):92-94.
Score: 0.075
-
Diagnosis of thrombotic thrombocytopenic purpura among patients with ADAMTS13 Activity 10%-20. Am J Hematol. 2017 Nov; 92(11):E644-E646.
Score: 0.066
-
Quinine-Induced Thrombotic Microangiopathy: A Report of 19 Patients. Am J Kidney Dis. 2017 Nov; 70(5):686-695.
Score: 0.065
-
Rituximab for thrombotic thrombocytopenic purpura: lessons from the STAR trial. Transfusion. 2017 10; 57(10):2532-2538.
Score: 0.065
-
Rituximab reduces risk for relapse in patients with thrombotic thrombocytopenic purpura. Blood. 2016 06 16; 127(24):3092-4.
Score: 0.060
-
Depression and cognitive impairment following recovery from thrombotic thrombocytopenic purpura. Am J Hematol. 2015 Aug; 90(8):709-14.
Score: 0.056
-
Plasma exchange complications in patients treated for thrombotic thrombocytopenia purpura-hemolytic uremic syndrome: 2011 to 2014. Transfusion. 2014 Dec; 54(12):3257-9.
Score: 0.054
-
Bone marrow necrosis discovered in a patient with suspected thrombotic thrombocytopenic purpura. Am J Hematol. 2015 Mar; 90(3):264-6.
Score: 0.054
-
Increased urinary albumin excretion following recovery from thrombotic thrombocytopenic purpura due to acquired ADAMTS13 deficiency. Am J Kidney Dis. 2014 Aug; 64(2):317-8.
Score: 0.052
-
Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura. Blood. 2013 Sep 19; 122(12):2023-9; quiz 2142.
Score: 0.049
-
Ten patient stories illustrating the extraordinarily diverse clinical features of patients with thrombotic thrombocytopenic purpura and severe ADAMTS13 deficiency. J Clin Apher. 2012; 27(6):302-11.
Score: 0.046
-
Prevalence of primary immune thrombocytopenia in Oklahoma. Am J Hematol. 2012 Sep; 87(9):848-52.
Score: 0.046
-
Diagnostic and therapeutic challenges in the thrombotic thrombocytopenic purpura and hemolytic uremic syndromes. Hematology Am Soc Hematol Educ Program. 2012; 2012:604-9.
Score: 0.044
-
Systemic infections mimicking thrombotic thrombocytopenic purpura. Am J Hematol. 2011 Sep; 86(9):743-51.
Score: 0.043
-
The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports. Am J Hematol. 2010 Mar; 85(3):174-80.
Score: 0.039
-
Frequency and significance of HIV infection among patients diagnosed with thrombotic thrombocytopenic purpura. Clin Infect Dis. 2009 Apr 15; 48(8):1129-37.
Score: 0.037
-
Cognitive deficits after recovery from thrombotic thrombocytopenic purpura. Transfusion. 2009 Jun; 49(6):1092-101.
Score: 0.036
-
Complications of plasma exchange in patients treated for thrombotic thrombocytopenic purpura. IV. An additional study of 43 consecutive patients, 2005 to 2008. Transfusion. 2009 Feb; 49(2):392-4.
Score: 0.036
-
Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trials. Br J Haematol. 2009 Feb; 144(3):409-15.
Score: 0.036
-
Long-term deficits in health-related quality of life after recovery from thrombotic thrombocytopenic purpura. Transfusion. 2009 Jan; 49(1):118-24.
Score: 0.035
-
Sporadic bloody diarrhoea-associated thrombotic thrombocytopenic purpura-haemolytic uraemic syndrome: an adult and paediatric comparison. Br J Haematol. 2008 May; 141(5):696-707.
Score: 0.034
-
Twice-daily plasma exchange for patients with refractory thrombotic thrombocytopenic purpura: the experience of the Oklahoma Registry, 1989 through 2006. Transfusion. 2008 Feb; 48(2):349-57.
Score: 0.033
-
Endemic Esherichia coil O157:H7 infections and hemolytic-uremic syndrome in Oklahoma, 2002-2005. J Okla State Med Assoc. 2007 Nov; 100(11):429-33.
Score: 0.033
-
Pancreatitis preceding acute episodes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: report of five patients with a systematic review of published reports. Haematologica. 2007 Jul; 92(7):936-43.
Score: 0.033
-
The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome Registry: a community service. J Okla State Med Assoc. 2007 Jul; 100(7):273-8.
Score: 0.033
-
Disseminated malignancy misdiagnosed as thrombotic thrombocytopenic purpura: A report of 10 patients and a systematic review of published cases. Oncologist. 2007 Jan; 12(1):11-9.
Score: 0.031
-
Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2006 May; 12(5):506-10.
Score: 0.030
-
The role of ADAMTS13 in the pathogenesis of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clin Adv Hematol Oncol. 2005 Aug; 3(8):627-32.
Score: 0.028
-
The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency. J Thromb Haemost. 2005 Jul; 3(7):1432-6.
Score: 0.028
-
The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS) Registry: a community perspective of patients with clinically diagnosed TTP-HUS. Semin Hematol. 2004 Jan; 41(1):60-7.
Score: 0.026
-
Initial management of immune thrombocytopenic purpura in adults: a randomized controlled trial comparing intermittent anti-D with routine care. Am J Hematol. 2003 Nov; 74(3):161-9.
Score: 0.025
-
Complete recovery from refractory immune thrombocytopenic purpura in three patients treated with etanercept. Am J Hematol. 2003 Jun; 73(2):135-40.
Score: 0.025
-
Salmonella sepsis caused by a platelet transfusion from a donor with a pet snake. N Engl J Med. 2002 Oct 03; 347(14):1075-8.
Score: 0.023
-
Quinine-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: frequency, clinical features, and long-term outcomes. Ann Intern Med. 2001 Dec 18; 135(12):1047-51.
Score: 0.022
-
Annual incidence and severity of acute episodes in hereditary thrombotic thrombocytopenic purpura. Blood. 2021 06 24; 137(25):3563-3575.
Score: 0.021
-
Thrombotic thrombocytopenic purpura-like syndromes following bone marrow transplantation: an analysis of associated conditions and clinical outcomes. Bone Marrow Transplant. 2001 Mar; 27(6):641-6.
Score: 0.021
-
Unintentional platelet removal by plasmapheresis. J Clin Apher. 2001; 16(2):55-60.
Score: 0.021
-
Management of patients with chronic, refractory idiopathic thrombocytopenic purpura. Semin Hematol. 2000 Jul; 37(3):290-8.
Score: 0.020
-
Shared decision making, thrombotic thrombocytopenic purpura, and caplacizumab. Am J Hematol. 2020 04; 95(4):E76-E77.
Score: 0.019
-
Acquired pure megakaryocytic aplasia report of two cases with long-term responses to antithymocyte globulin and cyclosporine. Am J Hematol. 1999 Oct; 62(2):115-7.
Score: 0.019
-
Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS) following treatment with deoxycoformycin in a patient with cutaneous T-cell lymphoma (Sezary syndrome): A case report. Am J Hematol. 1999 Aug; 61(4):268-70.
Score: 0.019
-
The International Hereditary Thrombotic Thrombocytopenic Purpura Registry: key findings at enrollment until 2017. Haematologica. 2019 10; 104(10):2107-2115.
Score: 0.018
-
Management of antithrombotic therapy in adults with immune thrombocytopenia (ITP): a survey of ITP specialists and general hematologist-oncologists. J Thromb Thrombolysis. 2018 Jul; 46(1):24-30.
Score: 0.017
-
Successful kidney transplantation in a patient with congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome). Transfusion. 2017 12; 57(12):3058-3062.
Score: 0.017
-
Clinical decisions in idiopathic thrombocytopenic purpura. Hosp Pract (1995). 1997 Sep 15; 32(9):159-60, 163-6, 169-70, passim.
Score: 0.016
-
Ribosomal and immune transcripts associate with relapse in acquired ADAMTS13-deficient thrombotic thrombocytopenic purpura. PLoS One. 2015; 10(2):e0117614.
Score: 0.014
-
Irinotecan-induced immune thrombocytopenia. Am J Med Sci. 2014 Feb; 347(2):167-9.
Score: 0.013
-
Pulmonary involvement in patients with thrombotic thrombocytopenic purpura. Eur J Haematol. 2014 Feb; 92(2):156-63.
Score: 0.013
-
A blinded study of bone marrow examinations in patients with primary immune thrombocytopenia. Eur J Haematol. 2013 Feb; 90(2):121-6.
Score: 0.012
-
Health care utilization of patients diagnosed with idiopathic thrombotic thrombocytopenic purpura in a commercially insured population in the United States. Transfusion. 2012 Jul; 52(7 Pt 2):1614-21.
Score: 0.011
-
Blood group O and black race are independent risk factors for thrombotic thrombocytopenic purpura associated with severe ADAMTS13 deficiency. Transfusion. 2011 Oct; 51(10):2237-43.
Score: 0.011
-
Fatigue in adult patients with primary immune thrombocytopenia. Eur J Haematol. 2011 May; 86(5):420-9.
Score: 0.011
-
Dose of prophylactic platelet transfusions and prevention of hemorrhage. N Engl J Med. 2010 Feb 18; 362(7):600-13.
Score: 0.010
-
Long-term, sub-clinical cardiac and renal complications in patients with multiple relapses of thrombotic thrombocytopenic purpura. Br J Haematol. 2010 May; 149(4):623-5.
Score: 0.010
-
Demographic and ADAMTS13 biomarker data as predictors of early recurrences of idiopathic thrombotic thrombocytopenic purpura. Eur J Haematol. 2009 Dec 01; 83(6):559-64.
Score: 0.009
-
Addendum to corticosteroid side effects and risk for bleeding in immune thrombocytopenic purpura: patient perspectives. Eur J Haematol. 2009 Nov; 83(5):497-8.
Score: 0.009
-
Corticosteroid side-effects and risk for bleeding in immune thrombocytopenic purpura: patient and hematologist perspectives. Eur J Haematol. 2009 Sep; 83(3):175-82.
Score: 0.009
-
Effect of prophylactic cyclosporine therapy on ADAMTS13 biomarkers in patients with idiopathic thrombotic thrombocytopenic purpura. Am J Hematol. 2008 Dec; 83(12):911-5.
Score: 0.009
-
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet. 2008 Feb 02; 371(9610):395-403.
Score: 0.008
-
Self-reported health-related quality of life in adults with chronic immune thrombocytopenic purpura. Am J Hematol. 2008 Feb; 83(2):150-4.
Score: 0.008
-
Thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation: an autopsy study. Transplantation. 2008 Jan 15; 85(1):22-8.
Score: 0.008
-
Cyclosporin and plasma exchange in thrombotic thrombocytopenic purpura: long-term follow-up with serial analysis of ADAMTS13 activity. Br J Haematol. 2007 Nov; 139(3):486-93.
Score: 0.008
-
A disease-specific measure of health-related quality of life in adults with chronic immune thrombocytopenic purpura: psychometric testing in an open-label clinical trial. Clin Ther. 2007 May; 29(5):950-962.
Score: 0.008
-
A disease-specific measure of health-related quality of life for use in adults with immune thrombocytopenic purpura: its development and validation. Health Qual Life Outcomes. 2007 Feb 22; 5:11.
Score: 0.008
-
An evaluation of cyclosporin and corticosteroids individually as adjuncts to plasma exchange in the treatment of thrombotic thrombocytopenic purpura. Br J Haematol. 2007 Jan; 136(1):146-9.
Score: 0.008
-
AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP. N Engl J Med. 2006 Oct 19; 355(16):1672-81.
Score: 0.008
-
ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood. 2003 Jul 01; 102(1):60-8.
Score: 0.006
-
Self-reported initial management of childhood idiopathic thrombocytopenic purpura: results of a survey of members of the American Society of Pediatric Hematology/Oncology, 2001. J Pediatr Hematol Oncol. 2003 Feb; 25(2):130-3.
Score: 0.006
-
A support group for patients who have recovered from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS): The six-year experience of the Oklahoma TTP-HUS Study Group. J Clin Apher. 2003; 18(1):16-20.
Score: 0.006
-
Predictive value of compression ultrasonography for deep vein thrombosis in symptomatic outpatients: clinical implications of the site of vein noncompressibility. Arch Intern Med. 2000 Feb 14; 160(3):309-13.
Score: 0.005
-
The clinical validity of normal compression ultrasonography in outpatients suspected of having deep venous thrombosis. Ann Intern Med. 1998 Jan 01; 128(1):1-7.
Score: 0.004